711219 45 '5

UUID:'?Z(152E248;-8Aﬁ\17664gglk EggB-SSEEFCDROgAaDacted ?12O15
lilliiiillillm 5 J1 Maﬁa raw/‘32:,
|||||||||||||||||||||||||llllllllllll|

I“ III |||||||lllllIIIIIIIIIIl||l||||l||l|l||l|||| ..
||l|||| Illllll|||||||IIIIIIIII|||||ll||||||l|||l||| || 7
III II |||||l||||||l|||| gp ﬁ/IS/IL/
Collect date:

(MM/DDIYYYY)

|
I
ii i
PATHOLOGY REPORT:

PRIMARY SITE: Bladder

"Bladder":

- Invasive urothelial carcinoma of high grade, vegetating, ulcerated inﬁltrative, of
brownish color, measuring 4.6 x 3.3 x 2.7cm, affecting leﬁ and right upper posterior

lateral wall, inﬁltrating muscularis propria and perivesical adipose tissue;
- Presence of perineural invasion;

- Angiolymphatic invasion not observed;
- Surgical margins free of neoplasia.

"Prostate":

- Prostate adenocarcinoma, usual acinar type, Gleason score 7 (3 +4) in the form of

Microscopic focus (2.0 mm) in the right apex, without extension to extraprostatic
tissues;

- Angiolymphatic and perineural invasions not observed
- Surgical margins of neoplasia;
- Nodular prostatic hyperplasia associated;

- Adjacent parenchyma without evidence of prostatic involvement by urothelial
carcinoma.

- Seminal vesicles and deferent ducts free of neoplasia.

 

PATHOLOGIC STAGING
Topography Morphology Stage
Bladder, NOS Transitional cell carcinoma, NOS pT3a

  
 
 

t Lola'!’

CHIEF-l»)

Diagnosis “M
f _l

 
       
 

army
Plimarv Tumo S te Discrepancy '—
HIPAA Discrepancy
‘ History .
Prior Malignancy I
' Not -
Dual/Synchronous Pnrnarv . ,

  

   
   
   

